| Trends in Pharmacological Sciences 2000 |
| Title | Subject | Authors |
|---|
| 2000 Receptor and Ion Channel Nomenclature Supplement.(Illustration) | Pharmaceuticals and cosmetics industries | |
| Anandamide and the question of its functional role for activation of capsaicin receptors.(Letter to the Editor)(Brief Article) | Pharmaceuticals and cosmetics industries | Szolcsanyi, Janos |
| An insight into arterial thrombosis?(Highlights) | Pharmaceuticals and cosmetics industries | Jarvis, Gavin |
| Beta-secretase revealed: starting gate for race to novel therapies for Alzheimer's disease.(Comment) | Pharmaceuticals and cosmetics industries | Skovronsky, Daniel M., Lee, Virginia M.-Y. |
| Central 5-HT(sub)1A receptors and vagal tone to the airways.(Brief Article)(Letter to the Editor) | Pharmaceuticals and cosmetics industries | Ramage, Andrew G. |
| Dopamine receptor partial agonists could address the duality of cocaine craving. | Pharmaceuticals and cosmetics industries | Childress, Anna Rose, O'Brien, Charles P. |
| Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'? | Pharmaceuticals and cosmetics industries | Marzo, Vincenzo Di, Bifulco, Maurizio, Petrocellis, Luciano De |
| G-protein-coupled receptor dimers in the lime light.(Comment and Reply) | Pharmaceuticals and cosmetics industries | Devi, Lakshmi A., Angers, Stephane, Bouvier, Michel |
| H3 receptor gene is cloned at last. | Pharmaceuticals and cosmetics industries | Leurs, Rob, Hoffmann, Marcel, Wieland, Kerstin, Timmerman, Henk |
| HIT dynamics are Fab.(heparin-induced thrombocytopenia)(Highlights) | Pharmaceuticals and cosmetics industries | Lever, Rebecca |
| Immunophilin ligands as a novel treatment for neurological disorders. | Pharmaceuticals and cosmetics industries | Herdegen, Thomas, Fischer, Gunter, Gold, Bruce G. |
| Internet resources for exploring gene family diversity.(Current Awareness) | Pharmaceuticals and cosmetics industries | Packer, Jeremy, Conley, Ed, Castle, Neil, Wray, Dennis, January, Craig, Patmore, Leslie |
| Learning about kainate receptors.(Comment) | Pharmaceuticals and cosmetics industries | Reid, Christopher A., Bliss, Tim V.P. |
| Maximal function of minimal K(sup)+ channel subunits.(Brief Article) | Pharmaceuticals and cosmetics industries | Sanguinetti, Michael C. |
| Mutants yield a pharmacophore model for the tubulin-paclitaxel binding site.(Comment and Reply) | Pharmaceuticals and cosmetics industries | Day, Billy W., Gussio, Rich, Fojo, Tito, Giannakakou, Paraskevi |
| Nitric oxide, glial cells and neuronal degeneration in parkinsonism.(Comment) | Pharmaceuticals and cosmetics industries | Hirsch, Etienne C., Hunot, Stephane |
| P2Y receptors: in the middle of the road. | Pharmaceuticals and cosmetics industries | Boeynaems, Jean-Marie, Communi, Didier, Savi, Pierre, Herbert, Jean-Marc |
| Phosphodiesterases: the journey towards therapeutics.(Meeting Report) | Pharmaceuticals and cosmetics industries | Torphy, Theodore J., Page, Clive |
| Proteases: from fertilization to cell death.(Meeting Report) | Pharmaceuticals and cosmetics industries | Bertenshaw, Greg P., Bond, Judith S. |
| Rational design of peptide agonists of cell-surface receptors. | Pharmaceuticals and cosmetics industries | Taylor, Simeon I. |
| Reply: 5-HT(sub)1A receptors and control of airways.(Trends Pharmacol. Sci. 21(6), 201, 2000)(Brief Article)(Letter to the Editor) | Pharmaceuticals and cosmetics industries | Cazzola, Mario |
| Reply: a sanguine approach to cannabis.(Trends in pharmacol. Sci, 21(6), 195, 2000)(Brief Article) | Pharmaceuticals and cosmetics industries | Baker, David |
| Schizophrenia, the dopamine hypothesis and alpha(sub)2-adrenoceptor antagonists.(Brief Article) | Pharmaceuticals and cosmetics industries | Lindstrom, Leif H. |
| Selective peptidomimetic blockers of autoantigen presentation: a novel therapeutic approach to autoimmune disease.(Comment) | Pharmaceuticals and cosmetics industries | Lehmann, Paul V. |
| The first 3D structure of arylamine N-acetyltransferase reveals a protease-like catalytic triad.(Highlights) | Pharmaceuticals and cosmetics industries | Payton, Mark |
| Transgenic xenosensors: humanizing mice.(Highlights) | Pharmaceuticals and cosmetics industries | Gillam, Elizabeth |
| Urotensin II: fish neuropeptide catches orphan receptor.(Comment) | Pharmaceuticals and cosmetics industries | Davenport, Anthony P., Maguire, Janet J. |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
